- Street: Kasterleesteenweg 272
- City: Vaux-Chavanne
- State: Indiana
- Country: Belgium
- Zip/Postal Code: 6960
- Listed: May 30, 2017 4:46 am
- Expires: 1 day, 8 hours
Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, including – http://venturebeat.com/?s=including the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use – and failure to accomplish so may be grounds for compensation. Our lawyers are operating challenging to get those hurt by the drug the compensation they are entitled to.
Although bleeding is really a typical complication related with anticoagulants, it has been alleged that Xarelto is far more unsafe than classic blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, within the event of an emergency, patients may possibly be at danger for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.
If you or possibly a loved 1 suffered a critical bleeding event right after taking Xarelto, you may have legal recourse. For much more info, speak to us these days to possess your case reviewed, cost-free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in instances of death, funeral expenses. In addition, they are seeking punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is xarelto an antithrombotic – http://xareltolegalline.bitbucket.org/categories/Michigan/Xarelto-Suit-New-Baltimore-MI-48051.html linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
Visit this page for more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
40 total views, 2 today